Related Experiment Video
Updated: Feb 25, 2026
09:13
Plasmonic Trapping and Release of Nanoparticles in a Monitoring Environment
Published on: April 4, 2017
8.0K
Plasmonic silver nanoshells for drug and metabolite detection
Lin Huang1, Jingjing Wan2, Xiang Wei1
1School of Biomedical Engineering, Children's Hospital of Shanghai, and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, 200030, People's Republic of China.
Nature Communications
|August 10, 2017
Summary
Researchers developed silver nanoshells for rapid metabolite and drug detection in bio-fluids, simplifying diagnostics and therapeutic monitoring. This advanced material enables direct analysis, improving precision diagnostics and disease management.
Area of Science:
- Materials Science
- Analytical Chemistry
- Biomedical Engineering
Background:
- In vitro metabolite and drug detection are crucial in biomedical research and clinical practice.
- Current metabolic analysis of bio-samples is hindered by complex preparation and low molecular abundance.
- Developing efficient diagnostic tools remains a significant challenge.
Purpose of the Study:
- To develop a novel materials-based analytical platform for direct metabolite and drug detection in bio-fluids.
- To utilize silver nanoshells for simplified and rapid analysis, aiding in disease diagnosis and therapeutic evaluation.
- To demonstrate the application of the platform in identifying postoperative brain infections and assessing drug distribution.
Main Methods:
- Synthesis of tunable SiO2@Ag silver nanoshells using multi-cycled silver mirror reactions.
- Direct laser desorption/ionization mass spectrometry (LDMS) using optimized nanoshells with minimal sample volume (0.5 μL).
- Application of the platform for glucose quantitation in cerebrospinal fluid for postoperative brain infection diagnosis and drug distribution analysis in blood and cerebrospinal fluid.
Main Results:
- Optimized silver nanoshells enabled direct LDMS analysis of bio-fluids, significantly reducing sample preparation.
- Successful identification of postoperative brain infection patients via daily monitoring and glucose quantitation in cerebrospinal fluid.
- Accurate measurement of drug distribution in blood and cerebrospinal fluid, validating blood-brain/cerebrospinal fluid barrier functions for pharmacokinetics.
Conclusions:
- The developed silver nanoshell platform offers an advanced approach for metabolic analysis and precision diagnostics.
- This technology simplifies bio-sample analysis, enabling faster disease diagnosis and more effective therapeutic monitoring.
- The findings highlight the potential of designed nanomaterials in creating next-generation diagnostic tools for clinical applications.
